about
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemicProcalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN731826Bacteriophage therapy of a Vibrio parahaemolyticus infection caused by a multiple-antibiotic-resistant O3:K6 pandemic clinical strain.Genome-scale identification method applied to find cryptic aminoglycoside resistance genes in Pseudomonas aeruginosa.Side chain hydrophobicity modulates therapeutic activity and membrane selectivity of antimicrobial peptide mastoparan-X.Natural Products as a Foundation for Drug Discovery.Crystallographic and molecular dynamics simulation analysis of Escherichia coli dihydroneopterin aldolase.Efficacy of the new lantibiotic NAI-107 in experimental infections induced by multidrug-resistant Gram-positive pathogens.High-throughput nano-biofilm microarray for antifungal drug discoveryAcinetobacter baumannii: emergence of a successful pathogenDeclines in outpatient antimicrobial use in Canada (1995-2010).Synthesis and structure-activity relationships of novel phenoxyacetamide inhibitors of the Pseudomonas aeruginosa type III secretion system (T3SS).Is antibiotic resistance a problem? A practical guide for hospital clinicians.Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): study protocol for a pilot randomized controlled trial.Structural and functional analysis of betaine aldehyde dehydrogenase from Staphylococcus aureus.Brief report: incidence, etiology, risk factors, and outcome of hospital-acquired fever: a systematic, evidence-based review.Enhancing the utility of existing antibiotics by targeting bacterial behaviour?Tigecycline: an evidence-based review of its antibacterial activity and effectiveness in complicated skin and soft tissue and intraabdominal infections.Bacterial membrane disrupting dodecapeptide SC4 improves survival of mice challenged with Pseudomonas aeruginosa.New advances in antibiotic development and discovery.National Institute of Allergy and Infectious Disease (NIAID) Funding for Studies of Hospital-Associated Bacterial Pathogens: Are Funds Proportionate to Burden of Disease?The Ethical Significance of Antimicrobial Resistance.Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria?Treatment options for multidrug-resistant bacteria.The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii.Design and Synthesis of Molecular Scaffolds with Anti-infective Activity.Prognostic value of procalcitonin in hospitalized patients with lower respiratory tract infectionsTruncated human cytidylate-phosphate-deoxyguanylate-binding protein for improved nucleic acid amplification technique-based detection of bacterial species in human samples.Outcome of acute prosthetic joint infections due to gram-negative bacilli treated with open debridement and retention of the prosthesisImpact of antimicrobial stewardship in critical care: a systematic review.Biochemistry of the non-mevalonate isoprenoid pathway.The potential of antimicrobial peptides as biocides.Antimicrobials, drug discovery, and genome mining.Antibiotic discovery: combatting bacterial resistance in cells and in biofilm communities.Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure-activity relationship analyses.Structure of ThiM from Vitamin B1 biosynthetic pathway of Staphylococcus aureus - Insights into a novel pro-drug approach addressing MRSA infections.Variability in antibiotic use across Ontario acute care hospitals.Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population.General practitioners' knowledge, attitude and prescribing of antibiotics for upper respiratory tract infections in Selangor, Malaysia: findings and implications.
P2860
Q24614464-ED3540CC-270C-491F-9A61-B95E77CFC0CDQ24815302-8E05E888-C692-4451-8C13-19C90DE4C3DFQ30359301-0B363A49-31FD-4A61-893A-84F01E6A175EQ30882914-06220AC1-CBA8-4D88-B8E6-95773D26C48AQ31153948-FC882FC3-9564-4706-AC83-EA546FDB2015Q33617301-6D0FC61B-2515-4F2F-857E-DB16DE496942Q34250767-4CE2EC09-FB96-4046-9730-6BE29A667BECQ34737510-3302C5B0-5B2B-4639-8CAF-7BD89A60150BQ34783867-00DE62DB-EE4C-465A-924F-0548F14D6952Q34795807-3459D7EE-5C4D-4156-81AA-AC0F93D9E469Q35022748-E7A477BF-4F3E-4DE6-8C55-A2F7AA757449Q35118409-503A61F3-313B-4FB3-AF1F-4D130921A63BQ35523222-CF8C93C5-BED9-4C81-87B9-1C0DEE1BA7BBQ35531132-59101E2E-4130-4C0B-BE40-10AFA2ACAFCBQ35592676-7AEDCA67-C261-4B4B-A6EB-892153BF989AQ35696376-F3AC16D2-A449-43A3-A7F8-41295B99F030Q35853204-9D70E835-C935-42A8-95CB-8E3A84F4BAA8Q35876393-2D59DD87-87DD-4AFB-8767-191561AA15D6Q35984984-AC33ED40-A533-462A-AB39-C22F39E04E1DQ36065983-D2480BCA-0CC6-453E-9219-672BD18CC31AQ36151660-49D034DD-05FE-4FEA-BD84-B0823AF37EB6Q36263119-D22313D0-A7D4-4709-8F17-A106FBAD4166Q36382134-B25CAED9-EA07-4D0E-A273-86B2679267EEQ36559365-ADEE61E4-8DE0-4F95-8C70-458069944CD9Q36607401-F339F0FD-D99C-40CC-B934-4C272FEA595AQ36956080-E70DB7AD-4656-4047-A475-A73809DB3E55Q36972421-AADD1BBB-0738-4580-A498-2D3E75E765A1Q37090231-03D16BEF-B5C3-413B-826A-584A1FF80A72Q37156880-6EFED6A6-95FE-42A1-BAEF-447D026992B6Q37409869-AB2F9AD1-8018-4A0E-8D73-4619671DB4F8Q37860821-6FC643D5-FF2E-4929-A7BC-CD7CFFEA4F35Q37899789-4DE7B8F1-0E98-4752-82C9-8BACBAF6CC7EQ37954604-50B72E06-8F11-484D-9D98-98BD90E38A69Q38066792-D80336A0-2442-4E14-AAA3-537071603E72Q38392008-5ECD02B5-0300-4DC7-937E-772C67278060Q38765020-CE14D893-50CE-44DD-AC27-19228086468EQ38891351-314A8A4C-A13A-41EC-99C3-FFF6E414BCB9Q39179486-067980F9-ADF9-4474-8D37-909D0E3115CCQ40531488-73137BA9-07A8-4509-B4DE-972E6FAC70E1Q41372131-9F7DB5DD-7C45-4701-BC33-1AEA5523CC43
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
The antibiotic pipeline--challenges, costs, and values.
@en
The antibiotic pipeline--challenges, costs, and values.
@nl
type
label
The antibiotic pipeline--challenges, costs, and values.
@en
The antibiotic pipeline--challenges, costs, and values.
@nl
prefLabel
The antibiotic pipeline--challenges, costs, and values.
@en
The antibiotic pipeline--challenges, costs, and values.
@nl
P356
P1476
The antibiotic pipeline--challenges, costs, and values.
@en
P2093
Richard P Wenzel
P304
P356
10.1056/NEJMP048093
P407
P577
2004-08-01T00:00:00Z